Clinical Trial Update: Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating asimadoline for diarrhea-predominant irritable bowel syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diarrhea-predominant Irritable Bowel Syndrome

Drugs mentioned

• Asimadoline (asimadoline)

Snippet

Sponsor: Tioga Pharmaceuticals | Conditions: Diarrhea Predominant Irritable Bowel Syndrome | Phase 3 | Status: COMPLETED